| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.66B | +18.3% |
| R&D Expense | $590.5M | +16.7% |
| SG&A Expense | $1.42B | -2.4% |
| Operating Income | -$65.5M | -138.5% |
| Interest Expense | $32.8M | -63.5% |
| Pre-tax Income | -$372.8M | -230.4% |
| Income Tax | -$158.6M | -173.4% |
| Net Income | -$224.1M | +32.0% |
| EPS (Basic) | -$3.58 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $881.5M | +49.0% |
| Accounts Receivable | $651.5M | +15.6% |
| Inventory | $714.1M | -33.4% |
| Current Assets | $2.61B | -0.2% |
| Total Assets | $10.84B | -11.9% |
| Current Liabilities | $933.2M | +15.3% |
| Long-term Debt | $5.72B | -5.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.27B | +63.4% |
| Capital Expenditures | $29.0M | +5.1% |
| Investing Cash Flow | -$446.2M | +91.4% |
| Financing Cash Flow | -$529.5M | -113.3% |
| Free Cash Flow | $1.24B | +65.5% |
| +35.1% |
| EPS (Diluted) | -$3.58 | +35.1% |
| Stockholders' Equity |
| $3.09B |
| -22.2% |